Both are non-hormonal vaginal moisturizers, but they work differently. Revaree uses hyaluronic acid in a vaginal insert format that draws and retains moisture within the tissue. A 2024 randomized trial at NYU found it performed comparably to vaginal estrogen cream. Replens uses polycarbophil in a gel format that coats the vaginal wall with a bioadhesive layer. Replens is more affordable and widely available. For moderate to severe dryness, Revaree has stronger clinical evidence. For mild dryness or budget-conscious use, Replens is a reasonable starting point. Both are safe for breast cancer survivors.
If you have been searching for a vaginal moisturizer and landed on the Revaree-vs-Replens question, you are in the right place. These are the two most commonly recommended non-hormonal vaginal moisturizers for menopause-related dryness, and they are not interchangeable. They use different active ingredients, different delivery formats, have different clinical evidence behind them, and cost very different amounts.
I am going to break down exactly how each one works, what the research shows, who each is best suited for, and which one I recommend as a starting point — with the evidence to back it up.
Before we compare, one critical distinction: vaginal moisturizers are not lubricants. Moisturizers are used regularly (every 2–3 days) to restore and maintain tissue hydration independent of sex. Lubricants are used during sex to reduce friction. If you have been using only a lubricant and wondering why the dryness persists between encounters, this is why. You almost certainly need both.
The Head-to-Head Comparison
| Factor | Revaree | Replens |
|---|---|---|
| Active ingredient | Hyaluronic acid (5mg per insert) | Polycarbophil (bioadhesive polymer) |
| Mechanism | Draws and retains up to 1,000x its weight in water within tissue | Coats vaginal wall with bioadhesive moisture layer |
| Format | Vaginal suppository (insert) — no applicator needed | Gel in pre-filled applicator |
| Frequency | Every 2–3 nights at bedtime | Every 3 days |
| Hormones | None | None |
| Breast cancer safe | Yes — included in MSK Cancer Center recommendations | Yes |
| Head-to-head clinical trial vs estrogen | Yes — 2024 NYU RCT showed comparable efficacy to vaginal estrogen cream at 12 weeks | No head-to-head non-inferiority data vs estrogen |
| User satisfaction data | National survey (n=3,080): 83% reduced dryness, 79% satisfied, 92% would recommend | General clinical support; no published large-scale satisfaction survey |
| Common complaints | Higher cost; occasional discharge; mild burning on initial use in severe atrophy | Thin texture; may require daily use; some report discharge; glycerin may irritate sensitive tissue |
| Approximate cost | $47–$62/month | $15–$20/month |
| Availability | Online (Bonafide website, Amazon); FSA/HSA eligible | Pharmacies, grocery stores, Amazon |
| Condom compatible | No (not compatible with condoms) | Compatible with latex and polyisoprene (not polyurethane) |
How Revaree Works
Revaree is made by Bonafide and contains 5mg of hyaluronic acid per vaginal insert. Hyaluronic acid is a molecule naturally produced throughout the body that plays a central role in cell hydration — each molecule can attract and retain up to 1,000 times its weight in water. When delivered directly to the vaginal tissue as a suppository, it draws moisture into the cells and supports tissue hydration, elasticity, and healing.
The insert is placed in the vagina at bedtime (no applicator required) and dissolves overnight. Bonafide recommends use every 2–3 nights. Most women report noticeable improvement within the first two weeks, with substantial results by day 30.
The Clinical Evidence for Revaree
This is where Revaree separates from most non-hormonal competitors. In a 2024 randomized pilot trial conducted at NYU Grossman School of Medicine and published in Menopause, women with GSM were assigned to either Revaree (hyaluronic acid insert) or vaginal estrogen cream (estradiol 0.01%) for 12 weeks. Both groups showed improvement in symptoms — including dryness, burning, irritation, and painful sex — and the level of improvement was not markedly different between the two treatments (LaPier et al., Menopause, 2024).
A 2023 systematic review across multiple studies similarly concluded that the efficacy of vaginal hyaluronic acid appears comparable to estrogen for treating vaginal atrophy symptoms (Albalawi et al., Cureus, 2023).
A national satisfaction survey of over 3,080 Revaree users found that 83% reported reduced vaginal dryness, 77% reported reduced irritation, 66% reported reduced pain during sex, and 92% would recommend it to others (Kaunitz et al., J Sex Med, 2022).
Samantha’s Recommended Starting Point
Revaree by Bonafide
Hyaluronic acid vaginal insert · 5mg per suppository · Non-hormonal · Clinically tested against vaginal estrogen · FSA/HSA eligible
Learn More →How Replens Works
Replens is a long-acting vaginal moisturizer that uses polycarbophil as its active ingredient — a bioadhesive polymer that attaches to the vaginal wall and holds moisture. It is applied using a pre-filled disposable applicator every three days. The gel coats the vaginal surface and provides a moisture layer that helps reduce dryness, itching, and discomfort.
Replens has been on the market for decades and is one of the most widely recognized vaginal moisturizer brands. It is available without a prescription at most pharmacies and grocery stores, and it is significantly less expensive than Revaree.
The Clinical Evidence for Replens
Replens has general clinical support for reducing vaginal dryness symptoms. The 2025 AUA/SUFU/AUGS guideline notes that vaginal moisturizers may improve vulvovaginal dryness (low certainty of evidence). However, Replens does not have a published head-to-head randomized controlled trial showing non-inferiority to vaginal estrogen — which is the key differentiator in Revaree’s clinical profile.
A 2018 study published in JAMA Internal Medicine found that both vaginal estrogen and a vaginal moisturizer (Replens) performed similarly to placebo for relieving dryness — though the authors noted that the placebo gel itself had lubricating properties that may have confounded results. This study is often cited but should be interpreted carefully.
Replens remains a reasonable first-line option for mild dryness, particularly for women who want a pharmacy-accessible, low-cost starting point.
Budget-Friendly Option
Replens Long-Lasting Vaginal Moisturizer
Polycarbophil bioadhesive gel · Non-hormonal · Available at pharmacies · Pre-filled applicator
Learn More →Who Should Choose Which
Choose Revaree if:
Your dryness is moderate to severe. The hyaluronic acid mechanism provides deeper, longer-lasting hydration than surface-level coating.
You want the strongest non-hormonal clinical evidence. Revaree is the only non-hormonal moisturizer with a published RCT showing comparable efficacy to vaginal estrogen.
You are a breast cancer survivor looking for a clinically validated, hormone-free option. MSK Cancer Center specifically recommends Revaree.
You prefer a suppository format over an applicator-based gel.
You have tried Replens and found it insufficient.
Choose Replens if:
Your dryness is mild. For early or intermittent dryness, Replens may provide adequate relief.
Budget is a primary concern. At roughly one-third the cost of Revaree, Replens is the most accessible option.
You want pharmacy availability. Replens is available at drugstores nationwide without ordering online.
You prefer a gel applicator format over a vaginal suppository.
You need condom compatibility. Replens is compatible with latex and polyisoprene condoms; Revaree is not condom-compatible.
Neither of these products is a substitute for vaginal estrogen in moderate to severe GSM. They are a first-line, non-hormonal option. If moisturizers alone are not providing adequate relief, vaginal estrogen is the next conversation to have with your provider.
A Note on What These Products Cannot Do
Vaginal moisturizers address dryness. They do not rebuild vaginal tissue thickness, restore elasticity at the cellular level, normalize vaginal pH, or reverse the broader tissue changes of GSM the way vaginal estrogen does. For mild dryness, a moisturizer may be all you need. For moderate to severe GSM, moisturizers are a complement to — not a replacement for — estrogen-based treatment.
If you have been using a moisturizer consistently for four to six weeks and your symptoms have not improved, the appropriate next step is a conversation with your provider about vaginal estrogen. In November 2025, the FDA removed the boxed warning from vaginal estrogen products, reflecting the established safety of low-dose local application.